Detalhe da pesquisa
1.
The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis.
Gut
; 65(6): 977-989, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25804630
2.
BIGH3 mediates apoptosis and gap junction failure in osteocytes during renal cell carcinoma bone metastasis progression.
Cancer Lett
; 596: 217009, 2024 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38849015
3.
Ligand-independent activation of MET through IGF-1/IGF-1R signaling.
Int J Cancer
; 133(7): 1536-46, 2013 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23526299
4.
Increased serum insulin-like growth factor-1 levels are associated with prolonged response to dasatinib-based regimens in metastatic prostate cancer.
Prostate
; 73(9): 979-85, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23371521
5.
Endothelial-to-osteoblast transition in normal mouse bone development.
iScience
; 26(2): 105994, 2023 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36798441
6.
Monitoring Glucocorticoid Receptor in Plasma-derived Extracellular Vesicles as a Marker of Resistance to Androgen Receptor Signaling Inhibition in Prostate Cancer.
Cancer Res Commun
; 3(12): 2531-2543, 2023 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37930121
7.
Characterization of prostate cancer adrenal metastases: dependence upon androgen receptor signaling and steroid hormones.
Prostate Cancer Prostatic Dis
; 26(4): 751-758, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36100698
8.
Prostate cancer-induced endothelial-to-osteoblast transition generates an immunosuppressive bone tumor microenvironment.
bioRxiv
; 2023 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38076845
9.
Retinoic Acid Receptor Activation Reduces Metastatic Prostate Cancer Bone Lesions by Blocking the Endothelial-to-Osteoblast Transition.
Cancer Res
; 82(17): 3158-3171, 2022 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35802768
10.
Prostate tumor-induced stromal reprogramming generates Tenascin C that promotes prostate cancer metastasis through YAP/TAZ inhibition.
Oncogene
; 41(6): 757-769, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34845375
11.
CHD1 Promotes Sensitivity to Aurora Kinase Inhibitors by Suppressing Interaction of AURKA with Its Coactivator TPX2.
Cancer Res
; 82(17): 3088-3101, 2022 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35771632
12.
Statins reduce castration-induced bone marrow adiposity and prostate cancer progression in bone.
Oncogene
; 40(27): 4592-4603, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34127814
13.
Multiple pathways coordinating reprogramming of endothelial cells into osteoblasts by BMP4.
iScience
; 24(4): 102388, 2021 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33981975
14.
P4HA2-induced prolyl hydroxylation suppresses YAP1-mediated prostate cancer cell migration, invasion, and metastasis.
Oncogene
; 40(41): 6049-6056, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34471235
15.
Radium-223 Treatment Increases Immune Checkpoint Expression in Extracellular Vesicles from the Metastatic Prostate Cancer Bone Microenvironment.
Clin Cancer Res
; 27(11): 3253-3264, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33753455
16.
Cabozantinib Reverses Renal Cell Carcinoma-mediated Osteoblast Inhibition in Three-dimensional Coculture In Vitro and Reduces Bone Osteolysis In Vivo.
Mol Cancer Ther
; 19(6): 1266-1278, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32220969
17.
Chromatin Regulator CHD1 Remodels the Immunosuppressive Tumor Microenvironment in PTEN-Deficient Prostate Cancer.
Cancer Discov
; 10(9): 1374-1387, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32385075
18.
BIGH3 Promotes Osteolytic Lesions in Renal Cell Carcinoma Bone Metastasis by Inhibiting Osteoblast Differentiation.
Neoplasia
; 20(1): 32-43, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29190493
19.
Targeting DNA Damage Response in Prostate Cancer by Inhibiting Androgen Receptor-CDC6-ATR-Chk1 Signaling.
Cell Rep
; 18(8): 1970-1981, 2017 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-28228262
20.
Androgen receptor inhibitor-induced "BRCAness" and PARP inhibition are synthetically lethal for castration-resistant prostate cancer.
Sci Signal
; 10(480)2017 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28536297